Decode News AI
简体繁體

FDA Clears Medtronic Hugo Robotic System for General Surgery Procedures

2026-11-17 11:46 EST · AI-compiled · 189 words · about 1 min · Views …

MINNEAPOLIS - Medtronic announced on November 17, 2026, that the U.S. Food and Drug Administration granted 510(k) clearance for its Hugo robotic-assisted surgery system across general surgery procedures.

Clearance Covers 3.5 Million Annual U.S. Surgeries

The expanded indication spans upper-abdominal procedures including cholecystectomy, Roux-en-Y gastric bypass, ventral hernia repair, and small bowel resection, alongside lower-abdominal inguinal hernia repair and appendectomy. Medtronic estimates these procedures account for roughly 3.5 million U.S. surgeries annually, representing more than half of all U.S. soft-tissue operations. The milestone follows urology clearance in December 2025 and LigaSure RAS Maryland clearance in September 2026.

Global System Installations Approach Fiscal Year Target

Medtronic expects Hugo to surpass 50,000 global procedures before the end of its fiscal year in April 2027, with approximately 250 installed systems worldwide. "Hugo expands choice with a practical option to help hospitals address capacity and access challenges, while giving surgical teams more flexibility to meet patients' needs across care settings," Medtronic executive Matt Anderson said. The approval positions Hugo as a broader competitor in U.S. minimally invasive robotic surgery.

Sources

Found a factual error or typo? Tell us

Follow Decode News AI on Telegram

Live updates: every new story is pushed the moment it publishes — dozens a day, no digest delay.

@decodenewsai · Subscribe now

Free · unsubscribe anytime

Comments